• Exchange: Abu Dhabi
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Gulf Pharmaceutical Industry-Julphar

+ Add to Watchlist

JULPHAR:UH

3.10 AED 0.000.00%

As of 06:00:03 ET on 10/30/2014.

Trading has been suspended for JULPHAR:UH

Snapshot for Gulf Pharmaceutical Industry-Julphar (JULPHAR)

Open: 3.10 Day's Range: 3.10 - 3.10 Volume: 0
Previous Close: 3.10 52wk Range: 2.74 - 3.70 1-Yr Rtn: +10.91%

Stock Chart for JULPHAR

No chart data available.
  • JULPHAR:UH 3.10
  • 1D
  • 1M
  • 1Y
3.10
Interactive JULPHAR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for JULPHAR

Current P/E Ratio (ttm) 12.5231
Estimated P/E(-) -
Relative P/E vs. ADSMI 0.9331
Earnings Per Share (ttm) 0.2475
Est. EPS -
Est. PEG Ratio -
Market Cap (M AED) 3,077.44
Shares Outstanding (M) 992.72
30 Day Average Volume 50,979
Price/Book (mrq) 1.5561
Price/Sale (ttm) 2.0619
Dividend Indicated Gross Yield 2.93%
Cash Dividend (AED) 0.0909
Dividend Ex-Date 04/17/2014
5 Year Dividend Growth 21.91%
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for JULPHAR

  • Revenue
  • Net Income (M/AED)
  • Profit Margin (%)

Company Profile & Key Executives for JULPHAR

Gulf Pharmaceutical Industries (JULPHAR) is involved in the development and production of medical drugs and various medical supplies in the United Arab Emirates.

Faisal Bin Saqr Al QasimiChairmanHassan Ahmed Al AkimVice Chairman
Ayman Ahmed SahliChief Executive OfficerG V G KrishnaChief Financial Officer
More Company Profile & Key Executives for JULPHAR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil